Castellan Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-78,223
Closed -$10.5M 63
2025
Q1
$10.5M Buy
78,223
+38,635
+98% +$5.09M 2.94% 11
2024
Q4
$5M Buy
39,588
+1,663
+4% +$247K 2.17% 22
2024
Q3
$6.3M Sell
37,925
-6,978
-16% -$1.06M 2.66% 11
2024
Q2
$5.97M Buy
+44,903
New +$5.41M 2.84% 9

Other funds holding THC

Castellan Group's THC Position: Q2 2025 in Review

Castellan Group sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 78,223 shares — an estimated $10.5M sold.

Castellan Group first reported a position in THC in Q2 2024 and held it in 4 quarters. The position peaked at $10.5M in Q1 2025. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

  • Castellan Group reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
  • Castellan Group sold 78,223 Tenet Healthcare shares in Q2 2025, an estimated $10.5M.
  • Castellan Group first reported a position in Tenet Healthcare in Q2 2024 and held it in 4 quarters.
  • Castellan Group's Tenet Healthcare position peaked at $10.5M in Q1 2025.
  • 626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Castellan Group's 13F filing for Q2 2025, filed 24 Jul 2025.